Press release
Liquid Biopsy Market Rising at 18% CAGR; Expected to Reach US$ 24.70 Billion by 2033
Liquid Biopsy Market
Liquid biopsy technology has emerged as a disruptive force globally. cancer diagnostics that offer non-invasive and highly sensitive approaches to cancer detection and monitoring. This innovative technology has attracted a lot of interest and seen tremendous growth as it has the potential to revolutionize cancer treatment. Liquid biopsies detect cancer biomarkers (such as those obtained from breast biopsies) from physiological fluids such as blood and urine.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9040
In the field of cancer diagnosis and treatment, a pioneering technology known as liquid biopsy is rapidly spreading and revolutionizing cancer detection and monitoring. Liquid biopsy involves the analysis of biomarkers such as circulating tumor cells (CTCs), cell-free DNA (cfDNA) and exosomes, which are secreted by tumors into body fluids such as blood or urine. This non-invasive approach offers several advantages over traditional tissue biopsies, including early detection, real-time monitoring of treatment response, and the possibility of individualized therapy. As this innovative technology gains momentum, the liquid biopsies market is witnessing significant growth and change.
One of the factors driving the liquid biopsies market is the rise in cancer worldwide. As the incidence of cancer increases and early detection is critical to improving patient outcomes, the demand for non-invasive and highly sensitive diagnostic tools increases. Liquid biopsy meets this need by providing a minimally invasive method for the detection of cancer-related biomarkers with high specificity and sensitivity. In addition, liquid biopsy has several advantages over conventional tissue biopsies, which often require invasive procedures and may not always provide representative samples. . A liquid biopsy can be performed more often and in a way with as little discomfort as possible to the patient, allowing real-time monitoring of the course of the disease and the response to treatment. In addition, liquid biopsy allows the detection of tumor heterogeneity, allowing doctors to better understand the genetic makeup of a patient's cancer and adapt treatment strategies accordingly.
The versatility of liquid biopsy extends from cancer detection to many applications, including minimal residual surveillance disease, assessment of treatment response and identification of drug resistance mutations. This versatile approach has led to the use of liquid biopsy in various types of cancer, including lung, breast, colon and prostate cancer.
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
Bio-Rad Laboratories
Biocept Inc.
Guardant Health
Illumina Inc.
F. Hoffman-La Roche Ltd.
Johnson & Johnson
Laboratory Corporation of America Holdings
MDxHealth SA
QIAGEN N.V
Thermo Fisher Scientific Inc.
QIAGEN;
Myriad Genetics, Inc;
ANGLE plc
Oncimmune
Lucence Health, Inc.
Freenome Holdings, Inc.
Epigenomics AG
Natera, Inc.
๐๐๐๐ ๐๐จ๐ซ๐:https://www.factmr.com/report/liquid-biopsy-market
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
The global liquid biopsies market has a variety of companies, from established diagnostic leaders to innovative startups, vying for position in this dynamic field.
Illumina, Inc., known for its genetic sequencing technology, is leading the way by offering significant high performance. sequencing technologies essential for various liquid biopsy procedures.
Guardant Health has rapidly gained recognition and market share for its innovative ctDNA analysis technology that is revolutionizing the detection of cancers.
Biocept specializes in providing comprehensive liquid biopsy testing services that ensure reliable cancer detection and follow-up for patients.
Focused on precision oncology, personal genomic diagnostics (PGDx) offers liquid biopsy solutions that aid in cancer diagnosis and treatment selection, promoting personalized patient care.
Known for its ctDNA testing platform, Natera has made significant advances in prenatal and liquid testing. areas of cancer biopsy that are pushing the boundaries of innovation.
This competitive environment, with established market leaders and innovative new entrants, is conducive to the continued development and expansion of the market, promising exciting advances in cancer diagnosis.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐๐ข๐ช๐ฎ๐ข๐ ๐๐ข๐จ๐ฉ๐ฌ๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก
By Product & Service :
Assay Kits
Instruments
Software and Services
By Circulating Biomarker :
Circulating Tumor Cells (CTCs)
Cell-free DNA
Circulating Cell-free RNA
Exosomes & Extracellular Vesicles
Others
By Indication :
Cancer
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Melanoma
Others
Non-cancer
Non-invasive Prenatal Testing (NIPT)
Organ Transplantations
Infectious Disease Testing
Others
By Technology :
Multi-gene-parallel Analysis (NGS)
Single-gene Analysis (PCR Microarrays)
By Clinical Application :
Routine Screening
Patient Work-up
Therapy Selection
Treatment Monitoring
Recurrence Monitoring
Others
By Sample Type :
Blood
Urine
Saliva
Others
By End User :
Hospitals & Laboratories
Specialty Centers
Research Institutes
Others
By Region :
North America
Europe
Latin America
East Asia
South Asia & Oceania
Middle East & Africa
The liquid biopsies market is growing rapidly as revolutionary cancer detection technology gains momentum. Due to its non-invasive nature, high sensitivity and versatility, liquid biopsy is poised to revolutionize cancer diagnosis and treatment, offering new hope to patients and healthcare providers. As research and development progresses, liquid biopsy may revolutionize cancer treatment, ultimately improving patient outcomes and saving lives.
๐๐จ๐ฉ ๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง ๐ญ๐ก๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ
Blood Collection Tubes for Liquid Biopsy Market
https://www.factmr.com/report/4495/blood-collection-tubes-for-liquid-biopsy-market
Breast Biopsy Marker Market
https://www.factmr.com/report/breast-biopsy-marker-market
Bone Biopsy Systems Market
https://www.factmr.com/report/3884/bone-biopsy-systems-market
๐๐จ๐ง๐ญ๐๐๐ญ:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
๐๐๐จ๐ฎ๐ญ ๐ ๐๐๐ญ.๐๐
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liquid Biopsy Market Rising at 18% CAGR; Expected to Reach US$ 24.70 Billion by 2033 here
News-ID: 3439902 • Views: โฆ
More Releases from Fact.MR
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decodingโฆ
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke โฆ
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleanersโฆ
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offeringโฆ
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 โฆ
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhanceโฆ
More Releases for Liquid
Vitamins: The Liquid Goldmine in the Booming Liquid Dietary Supplements Market
The liquid dietary supplements market is experiencing a surge in popularity, driven by consumers seeking convenient and effective ways to boost their health and wellness. Among the diverse offerings, the vitamins segment stands out as a high-opportunity area, catering to a wide range of health needs and preferences.
Market Dynamics and Growth Drivers
Liquid vitamins offer a compelling alternative to traditional pills and capsules, providing faster absorption, easier consumption, and customizable dosages.โฆ
Thermoelectric Assemblies Market, By Type (Air to Air, Direct to Air, Liquid to โฆ
The thermoelectric assemblies market is expected to witness market growth at a rate of 8.25% in the forecast period of 2021 to 2028. Data Bridge Market Research report on thermoelectric assemblies market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in the application of thermoelectric assemblies in the food and beverage industryโฆ
Southeast Asia Liquid Gases Market : Growing with a CAGR of 7.1%, By Type (Liqui โฆ
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged productsโฆ
Southeast Asia Liquid Gases Market growing with a CAGR of 7.1%, By Type (Liquid โฆ
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged productsโฆ
Southeast Asia liquid gases market growing with a CAGR of 7.1%, Size, Share, Tre โฆ
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged productsโฆ
Dual Chamber Prefilled Syringes Market 2021 by Product (Liquid/Powder, Liquid/Li โฆ
The Dual Chamber Prefilled Syringes Market report examines the market size by vital countries/regions, product type, application, historical data, and estimate to forecast. It helps to understand the structure of the Dual Chamber Prefilled Syringes Market by recognizing its different sub-segments. Furthermore, the report focuses on key market players to determine, describe and analyze the value, market share, market competition landscape, SWOT analysis, and development plans in the next fewโฆ
